#BREAKING: Zim To Switch To New ARV Drug With Less Side Effects
ZIMBABWE is ready to transition to Teno-Lamuvudine Dolutegrevir (TLD), an Anti-retro Viral (ARV) drug with less side effects, moving away from the Teno-Lamivudine-Efavirenz (TLE) a three in one drug that is taken once a day, a top health official has said By Michael Gwarisa The development comes barely a year after government through the Ministry
Read More
Structural & Ecological Approach Key To Advancing SRH Services Among Zim Youths
YOUTHS are a critical constituency in every given society and it is that period in life when one is young, and often refers to the phase between childhood and adulthood. The African Youth Charter defines youths or young people as every person between the ages of 15 and 35 years while the United Nations defines
Read More
Zim Has Enough Blood Stocks
THE country has enough blood stocks to sustain the national demand, contrary to media reports that the blood bank was facing acute blood shortages, National Blood Service of Zimbabwe (NBSZ) Public Affairs Manager, Ms Esther Massundah has said. By Michael Gwarisa In a statement, Ms Massundah said blood has a shelf life of 42 days
Read More